Redsense Medical AB (publ) Stock Nasdaq Stockholm
Equities
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- | - |
Feb. 27 | Redsense Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Feb. 06 | Redsense Medical Late Board Chair's Company to Retain Shares | MT |
Sales 2022 | 16.75M 1.55M 0 | Sales 2023 | 25.52M 2.36M 0 | Capitalization | 107M 9.87M 0 |
---|---|---|---|---|---|
Net income 2022 | -8M -740K - | Net income 2023 | -4M -370K - | EV / Sales 2022 | 7.31 x |
Net cash position 2022 | 10.58M 978K 0 | Net cash position 2023 | 6.97M 644K 0 | EV / Sales 2023 | 3.91 x |
P/E ratio 2022 |
-15.2
x | P/E ratio 2023 |
-23.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Pontus Nobreus
CEO | Chief Executive Officer | 60 | 22-04-30 |
Jennie Kardell
DFI | Director of Finance/CFO | - | 22-12-31 |
Sebastien Bollue
COO | Chief Operating Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susanne Olausson
BRD | Director/Board Member | 53 | 12-12-31 |
Eva Walde
CHM | Chairman | 61 | 22-12-31 |
Malin Almgren
BRD | Director/Board Member | - | 22-12-31 |
1st Jan change | Capi. | |
---|---|---|
-1.89% | 12.56B | |
-9.59% | 7.68B | |
-1.31% | 5.29B | |
+21.82% | 5.18B | |
+0.02% | 4.57B | |
-50.89% | 3.29B | |
+6.42% | 2.6B | |
-10.02% | 2.2B | |
-8.29% | 1.79B |